Seer Bio

SEER Micro Cap

Healthcare · Biotechnology

Updated: Apr 5, 2026, 17:43 UTC

$1.70

+0% today

52W: $1.64 – $2.41

52W Low: $1.64 Position: 7.8% 52W High: $2.41

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

—

Forward Price/Earnings

P/S Ratio

5.79x

Price-to-Sales

EV/EBITDA

0.92x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$95.9M

Market Capitalization

Revenue Growth

YoY Revenue Growth

Profit Margin

—

Net profit margin

ROE

-25.08%

Return on Equity

Beta

1.6

Market sensitivity

Short Interest

1.41%

% of float sold short

Avg. Volume

270,134

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

0 analysts

About the Company

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to su

Sector: Healthcare Industry: Biotechnology Country: United States Employees: 124 Exchange: NMS